BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 11921662)

  • 1. Alternative fixation of bioprostheses.
    Hendriks M; Everaerts F; Verhoeven M
    J Long Term Eff Med Implants; 2001; 11(3-4):163-83. PubMed ID: 11921662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioprostheses and its Alternative Fixation.
    Hendriks M; Everaerts F; Verhoeven M
    J Long Term Eff Med Implants; 2017; 27(2-4):137-157. PubMed ID: 29773037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amide cross-linking: an alternative to glutaraldehyde fixation.
    Girardot JM; Girardot MN
    J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the cross-linking characteristics of porcine heart valves fixed with glutaraldehyde or epoxy compounds.
    Sung HW; Shen SH; Tu R; Lin D; Hata C; Noishiki Y; Tomizawa Y; Quijano RC
    ASAIO J; 1993; 39(3):M532-6. PubMed ID: 8268592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of calcification of carbodiimide-processed heart valve tissue by prior blocking of amine groups with monoaldehydes.
    Everaerts F; Gillissen M; Torrianni M; Zilla P; Human P; Hendriks M; Feijen J
    J Heart Valve Dis; 2006 Mar; 15(2):269-77. PubMed ID: 16607911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diamine-extended glutaraldehyde- and carbodiimide crosslinks act synergistically in mitigating bioprosthetic aortic wall calcification.
    Zilla P; Bezuidenhout D; Torrianni M; Hendriks M; Human P
    J Heart Valve Dis; 2005 Jul; 14(4):538-45. PubMed ID: 16116882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutaraldehyde fixation revisited.
    Nimni ME
    J Long Term Eff Med Implants; 2001; 11(3-4):151-61. PubMed ID: 11921661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A multi-step approach in anti-calcification of glutaraldehyde-preserved bovine pericardium.
    Neethling WM; Hodge AJ; Clode P; Glancy R
    J Cardiovasc Surg (Torino); 2006 Dec; 47(6):711-8. PubMed ID: 17043620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammatory and immune processes: the neglected villain of bioprosthetic degeneration?
    Human P; Zilla P
    J Long Term Eff Med Implants; 2001; 11(3-4):199-220. PubMed ID: 11921664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model.
    Weissenstein C; Human P; Bezuidenhout D; Zilla P
    J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fixation of Bovine Pericardium-Based Tissue Biomaterial with Irreversible Chemistry Improves Biochemical and Biomechanical Properties.
    Tam H; Zhang W; Infante D; Parchment N; Sacks M; Vyavahare N
    J Cardiovasc Transl Res; 2017 Apr; 10(2):194-205. PubMed ID: 28213846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a polyepoxy compound fixed porcine heart valve bioprosthesis.
    Shen SH; Sung HW; Tu R; Hata C; Lin D; Noishiki Y; Quijano RC
    J Appl Biomater; 1994; 5(2):159-62. PubMed ID: 10147176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stentless valves treated by the L-hydro process in the aortic position in sheep.
    Santos PC; Gerola LR; Casagrande I; Buffolo E; Cheung DT
    Asian Cardiovasc Thorac Ann; 2007 Oct; 15(5):413-7. PubMed ID: 17911070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcification of tissue heart valve substitutes: progress toward understanding and prevention.
    Schoen FJ; Levy RJ
    Ann Thorac Surg; 2005 Mar; 79(3):1072-80. PubMed ID: 15734452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fixation-related autolysis and bioprosthetic aortic wall calcification.
    Human P; Weissenstein C; Trantina A; Zilla P
    J Heart Valve Dis; 2001 Sep; 10(5):656-65. PubMed ID: 11603606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PhotoFix: unraveling the mystery.
    Moore MA
    J Long Term Eff Med Implants; 2001; 11(3-4):185-97. PubMed ID: 11921663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Degeneration of bioprosthetic heart valve cusp and wall tissues is initiated during tissue preparation: an ultrastructural study.
    Simionescu DT; Lovekamp JJ; Vyavahare NR
    J Heart Valve Dis; 2003 Mar; 12(2):226-34. PubMed ID: 12701796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine aortic wall flexibility. Fresh vs Denacol fixed vs glutaraldehyde fixed.
    Zhou J; Quintero LJ; Helmus MN; Lee C; Kafesjian R
    ASAIO J; 1997; 43(5):M470-5. PubMed ID: 9360087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neomycin and carbodiimide crosslinking as an alternative to glutaraldehyde for enhanced durability of bioprosthetic heart valves.
    Leong J; Munnelly A; Liberio B; Cochrane L; Vyavahare N
    J Biomater Appl; 2013 May; 27(8):948-60. PubMed ID: 22207605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detoxification on top of enhanced, diamine-extended glutaraldehyde fixation significantly reduces bioprosthetic root calcification in the sheep model.
    Trantina-Yates AE; Human P; Zilla P
    J Heart Valve Dis; 2003 Jan; 12(1):93-100; discussion 100-1. PubMed ID: 12578343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.